This website provides a curated collection of resources about the people, places and technologies that have enabled biotechnology to transform our healthcare and the world we live in today
antibodies: Timeline of key events
To search for particular terms in the description of the event enter the term in the box below 'Event' on the table and press 'enter'. Alternatively use the dropdown lists to filter by Person, Place or Science. Click here to clear the filter.
|24 Oct 2016||FDA approved pembrolizumab (Keytruda®) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1 as determined by an FDA-approved test.||Merck||Immune checkpoint inhibitors, Immunotherapy, Oncology, Monoclonal antibodies|
|17 Mar 2017||Monoclonal antibody shown to effectively cut cholesterol levels, thereby preventing heart attacks and strokes||Sabatine||Monoclonal antibodies, Cardiovascular|
|23 Mar 2017||US FDA granted accelerated approval to avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma||EMD Serono||Immune checkpoint inhibitors, Immunotherapy, Oncology, Monoclonal antibodies|
Follow us to keep up with all the new content about the world of biotechnology.